7.00
Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten
Can Candel Therapeutics Inc. stock recover from recent declineExceptional return forecasts - jammulinksnews.com
Small cap wrap: Blockmate Ventures, Candel Therapeutics, HIVE Digital, American Resources... - Proactive financial news
Candel Therapeutics receives EMA Orphan Designation for immunotherapy candidate CAN-2409 - Proactive financial news
Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer - GlobeNewswire
Revolutionary Pancreatic Cancer Treatment Shows 31.4-Month Survival, Secures Critical EU Designation - Stock Titan
Is Candel Therapeutics Inc. a good long term investmentSuperior profit margins - jammulinksnews.com
Candel Therapeutics Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com
What drives Candel Therapeutics Inc. stock priceTremendous portfolio expansion - jammulinksnews.com
What analysts say about Candel Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional
(CADL) Trading Report - news.stocktradersdaily.com
What makes Candel Therapeutics Inc. stock price move sharplyShort Squeeze Radar - beatles.ru
Candel Therapeutics (CADL) Shares Soar 9.60% - AInvest
Candel Therapeutics (CADL) Has a New Rating from Freedom Capital Markets - The Globe and Mail
Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating - Investing.com Nigeria
Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating By Investing.com - Investing.com South Africa
(CADL) Investment Report - news.stocktradersdaily.com
Brookline Capital Initiates Candel Therapeutics(CADL.US) With Buy Rating, Announces Target Price $25 - 富途牛牛
Candel Therapeutics Added to Russell Indexes, Analysts Forecast Upside of 319.85% - AInvest
Candel Therapeutics added to multiple Russell value indexes By Investing.com - Investing.com South Africa
Brookline Capital initiates Candel Therapeutics stock with Buy rating, $25 target - Investing.com Nigeria
Candel Therapeutics Added To Multiple Russell Value Indexes In 2025 Reconstitution - 富途牛牛
Market movers: Meta, Nvidia, Candel Therapeutics, Ocean Power Technologies... - Proactive financial news
Candel Therapeutics: Russell Inclusion and Clinical Catalysts Drive Biotech Upside - AInvest
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution - The Manila Times
Candel Therapeutics added to multiple Russell value indexes - Investing.com
Candel Therapeutics, Inc. Gains Inclusion in Multiple Russell Value Indexes During 2025 Annual Reconstitution - Quiver Quantitative
Candel Therapeutics Expands Russell Index Presence with - GlobeNewswire
Candel Therapeutics expands Russell Index presence following 2025 reconstitution - Proactive financial news
Candel Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com India
One Candel Therapeutics Insider Raised Stake By 22% In Previous Year - Yahoo Finance
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Market movers: Carnival, Uber, Ideal Power, Candel Therapeutics... - Proactive Investors
Candel Therapeutics announces $15M direct offering to support CAN-2409 launch preparations - Proactive Investors
Candel Therapeutics names Charles Schoch as CFO after interim tenure - Proactive financial news
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer - The Globe and Mail
Trend Tracker for (CADL) - news.stocktradersdaily.com
Candel Therapeutics Elects New Directors at Annual Meeting - TipRanks
Candel Therapeutics, Inc.'s (NASDAQ:CADL) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures - simplywall.st
Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire
Candel Therapeutics, Inc. (NASDAQ:CADL) Shares Purchased by Squarepoint Ops LLC - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):